Rajshree Polypack Limited has informed the Exchange about Capacity addition

Capex & Operations View source PDF Explain this filing

RPPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.2%Reaction day

₹24.38

prior close

₹25.23

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+2.6% vs market

Packaging peers, median of 64sector+0.0%+3.2% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 3.2 pts more than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

+0.8

15m

-0.1

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.2+0.5+2.6+0.0+3.2

Next day

+0.7+0.2+0.5-0.4+1.1

+2.8-0.9+3.7-0.5+3.3

+4.0-1.2+5.2-0.9+4.9

+0.5-2.0+2.6-1.2+1.7

+1.7-1.9+3.6-2.0+3.8

-1.6-1.2-0.4-1.9+0.3

15d

-9.4-1.5-7.8-2.3-7.0

-11.5+0.0-11.6+0.0-11.6

-19.4-0.5-19.0-0.8-18.7

-20.6+1.3-21.9-1.6-19.1

UpDownMarket · Nifty Microcap 250Sector · Packaging peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rajshree Polypack has added 600 Metric Tonnes Per Annum (MTPA) of new production capacity for food packaging containers made via the injection moulding process. The additional capacity has been set up at the end of a toll manufacturer, and commercial production has already started. With this addition, the company's total installed capacity for injection moulding products now stands at 4,800 MTPA. This is a follow-up to earlier intimations made on May 26, 2025 and July 2, 2025.

Likely market impact

This is a modest capacity expansion (about 12-13% increase in injection moulding capacity) executed through a toll manufacturing arrangement, which means lower capital outlay for the company. It is mildly positive as it supports future revenue growth, but the small size and toll-based model limit the immediate impact on shareholders or stock price.